BRING A WATCHFUL EYE AND SOUND DECISION MAKING TO YOUR BUSINESS

for High Performance and Long-term Sustainability

COMPLIANCE, GOVERNANCE & DUE DILIGENCE

CRS can help your organization balance the need to protect its integrity and reputation with maximizing business performance. Look at our team as a reality check on your organization, enabling your business to grow faster without veering off the track.

 

EU MDR

We know the intricacies of how to interpret and apply the EU MDR especially related to risk management, clinical evidence, post-market follow-up studies and routine surveillance and complaint handling. We will help you gain compliance and be inspection-ready. We can write your clinical evaluation reports and literature reviews and build a defendable maintenance plan. This includes your clinical evaluation plan and/or post-market clinical follow-up plans per device family.

SOPs

We customize and build your quality management system from scratch: medical device, clinical affairs and quality assurance components. We are also prepared to harmonize your SOPs post acquisition of other entities.

Governance

We review your corporate policies and identify gaps or business contradictions. We write the policy, train your staff and help ensure you are keeping squeaky clean. Our latest projects: ICH GCP / ISO14155 Compliance, 21 CFR 312, 21 CFR 812, GDPR, HIPAA/Privacy, Travel Policies, Confidentiality, Code of Ethics and Conduct, and Publications Policy. What better way to establish and maintain a healthy and sustainable, transparent culture of trust between staff and clients.

Trial Master File (TMF) Management

Our experienced team of senior research consultants builds, repairs and maintains a clinical trial’s TMF in paper or in electronic format. We have used numerous e-TMF systems and can take on the hardest program for the life cycle, for auditing a TMF, or for rescuing a TMF from other parties.

Due Diligence

We assess the quality of clinical data and quality management systems to de-risk an acquisition target. Through our other partners, we can aid in deeper multi-disciplinary dive and review.

 

Here’s what else we can do…

  • Executive-level Corporate Start-up and Corporate Operations
  • Perform Quality Assurance Audits
  • Prepare you for Inspection-Readiness
  • Assist with 483 and Warning Letter Remediation
  • Create a Fair Market Value Analysis
  • Create Corporate Sustainability Plans
  • Perform Risk Assessments and Gap Analyses
  • Establish Requirements for Contract Management
  • Develop HR Functions, On-boarding Plans, and Employee Development Programs
  • Customize Job Descriptions and Organizational Manuals
  • Lead KOL, Scientific, Medical Advisory Board Contracting and Management
  • Write Committee Charters
Medical Equipment

Are Your Medical Products EU Reg-Ready for 2021?

Due to COVID-19, the EU revised the MDR date for conformance and moved it to May 2021. Your medical devices need to be prepared for quality system audits and, depending on the type of device, a review of safety and performance documentation. If you’re unsure about how your products stack up, the CRS team of clinical, science, engineering, and regulatory advisors can assist with the latest requirements to help you comply.

CLINICAL RESEARCH STRATEGIES

An End-to-End Approach to Compliance in Life Sciences

Life Sciences Review, March 2021

“In the EU, while regulations are meant for ensuring patients’ safety by adding more conformance requirements, they have severely compromised the Life Sciences industry’s quest to push the boundaries of innovation,” says Alethea Wieland, the President and Founder of Clinical Research Strategies.

According to a study published by Deloitte, “Globalization, alliances and partnerships, heightened transparency expectations, increased emphasis on innovative technologies, and ever-evolving needs for existing and emerging customers are driving them to re-examine their approach to compliance.”

As such, identifying, analyzing, and mitigating compliance risks have evolved into a fundamental prerequisite for Life Sciences companies in developing an effective strategy to help future-proof their business. However, keeping up the innovation pace with this regulatory landscape will no longer be an easy task, especially for startups and mid-sized organizations.

Life Sciences Review Article

Read the full article online at Life Sciences Review.

WILL YOU BE READY WHEN INSPECTORS SHOW UP AT YOUR DOOR?

Establishing a trial master file (TMF) plan and audit schedule are vital to the success of every clinical trial. Waiting until the 11th hour will compromise your ability to ensure that your documentation fully complies and is ready for inspection.

Be prepared when it matters most.

CRS CAN PLAY A VITAL ROLE IN MAINTAINING THE HEALTH OF YOUR BUSINESS

Let’s talk about bringing integrity, trust and accountability to your entire operation.

Share This